Resonance Specialties Board of Directors

Get the latest insights into the leadership at Resonance Specialties. Learn about the experienced professionals guiding the company's strategy and governance.

NamePosition
Mrs. Archana Yadav Chairperson & Independent Director
Mr. Charchit Jain WholeTime Director & CFO
Mr. Prashant Godha Non Executive Director
Mr. Nilesh Jain Non Executive Director
Mr. Raj Kamal Prasad Verma Independent Director
Mr. Ajay Patadia Independent Director

Resonance Specialties Share price

RESONANCE

101.35

0.10 (-0.10%)
Last updated on 4 Sep, 2025 | 15:29 IST
BUYSELL
Today's High

104.10

Today's Low

100.70

52 Week Low

65.00

52 Week High

124.50

The current prices are delayed, login to your account for live prices

Resonance Specialties FAQs

The board at Resonance Specialties consists of experienced professionals, including Mrs. Archana Yadav , Mr. Charchit Jain , and others, overseeing the company’s strategic and corporate governance.

Directors at Resonance Specialties are typically nominated by the Nomination and Remuneration Committee and approved by shareholders, adhering to regulatory and governance standards. While this is the standard procedure, the exact process may differ depending on the company’s internal policies and governance framework.

As of the latest update, Mrs. Archana Yadav is the current chairman at Resonance Specialties.

Executive directors at Resonance Specialties are involved in day-to-day operations, while non-executive directors, including independents, provide oversight and strategic input. While this distinction is generally followed, the specific responsibilities of executive and non-executive directors may vary based on the company’s organisational structure and governance practices.

Yes, Resonance Specialties adheres to all applicable SEBI and Companies Act provisions related to board structure, diversity, and independence.

At Resonance Specialties, board members usually serve fixed terms as outlined in the company’s charter or governance policy, commonly ranging between three to five years, with the possibility of renewal based on performance, shareholder approval, and regulatory norms.